News - A groundbreaking noninvasive therapy has been introduced for prostate cancer in New Jersey.

MD Anderson at Cooper is leading the charge in advanced prostate cancer care with the introduction of an innovative, noninvasive treatment—robotic high-intensity focused ultrasound (HIFU). This cutting-edge therapy targets prostate tumors precisely with ultrasound waves, heating and obliterating cancerous tissue while sparing surrounding healthy areas. This advanced procedure is now accessible to select patients in southern New Jersey, marking Cooper as one of the region's pioneers in offering such technology. The treatment involves no incisions, radiation, or surgical removal of the prostate, ensuring that the focus remains solely on the diseased part of the gland. This results in a significant decrease in side effects like urinary incontinence and erectile dysfunction, allowing many patients to resume their daily activities with minimal interruption soon after the procedure. According to Dr. Jeffrey J. Tomaszewski, leading the charge in urology and genitourinary oncology at MD Anderson Cancer Center at Cooper, recent studies, including the extensive HIFI Study, provide compelling evidence of the efficacy of HIFU. Findings from over 3,000 participants in 46 centers show improved postoperative outcomes concerning urinary continence and erectile function compared to traditional surgical methods. Cooper's integration of robotic HIFU not only enhances its prostate cancer treatment repertoire but also signifies a broader movement towards more targeted and life-quality-preserving cancer treatments. Patients can inquire about this therapy by contacting MD Anderson Cancer Center at Cooper directly at 855.MDA.COOPER. In partnership with Cooper Medical School of Rowan University, Cooper University Health Care encompasses a widespread network including three hospitals and numerous outpatient facilities, delivering comprehensive healthcare services to over 2.4 million patients annually. The health system prides itself on being recognized by Forbes as one of America's Best Large Employers. The addition of this state-of-the-art procedure at Cooper marks a new era in prostate cancer care, emphasizing less invasive methods that align cancer control with maintaining patient quality of life.